Format

Send to

Choose Destination
Sci Transl Med. 2014 Nov 5;6(261):261fs45. doi: 10.1126/scitranslmed.3010444.

Public biobanks: calculation and recovery of costs.

Author information

1
INSERM, National Biobank Infrastructure, Paris, France. INSERM, CRB-Santé and U-991, Pontchaillou Hospital, Rennes, France. bruno.clement@inserm.fr.
2
Centre for Integrated Genomic Medical Research, University of Manchester, Manchester, UK.
3
Institute of Pathology, Medical University of Graz, Graz, Austria.
4
Institute of Epidemiology, Helmholtz Center, Munich, Germany.
5
Biobank, IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Genoa, Italy.
6
Biobank, Wroclaw Research Centre, EIT+, Wrocław, Poland.
7
Institut Pasteur, Paris, France.
8
INSERM, National Biobank Infrastructure, Paris, France. Hospital-Integrated Tumor Biobank, Pasteur Hospital, Nice, France.
9
INSERM, National Biobank Infrastructure, Paris, France.

Abstract

A calculation grid developed by an international expert group was tested across biobanks in six countries to evaluate costs for collections of various types of biospecimens. The assessment yielded a tool for setting specimen-access prices that were transparently related to biobank costs, and the tool was applied across three models of collaborative partnership.

PMID:
25378642
DOI:
10.1126/scitranslmed.3010444
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center